[Form 4] Medpace Holdings, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings, Inc. disclosed that Executive Vice President of Operations Susan E. Burwig received new equity awards. She was granted 5,000 restricted stock units, each representing a contingent right to receive one share of MEDP common stock, and 10,000 employee stock options with an exercise price of $410.54 per share, expiring on April 24, 2033. Both the options and the restricted stock units vest in full on the second anniversary of the grant date, subject to her continued employment with Medpace or one of its subsidiaries. Following these transactions, she directly holds 70,484 shares of Medpace common stock, along with the newly granted awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
BURWIG SUSAN E
Role
Exec. VP, Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 5,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 10,000 shares (Direct, null);
Restricted Stock Unit — 5,000 shares (Direct, null);
Common Stock — 70,484 shares (Direct, null)
Footnotes (1)
- The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
